·Î°í

¿¬±¸¼Ò ¼Ò°³ ¿¬±¸¼Ò Ȱµ¿ Áø·á¾È³» Ä¿¹Â´ÏƼ
Home Sitemap
´º½º Çà»ç
  • °í´ë±¸·Îº´¿ø, Á¦1ȸ ¡®ÀÏŸ¾Ï°­ÁÂ, ¾Ï! À̱âÀÚGuro¡¯¡¦

    2023-06-22
  • °í´ë±¸·Îº´¿ø, Ç×¾ÏÁ¦ Á¶Á¦·Îº¿ 'APOTECA Chemo' µµÀÔ¡¦

    2023-06-22
  • °í·Á´ë ±¸·Îº´¿ø 'Çõ½ÅÇü ÀÇ»ç°úÇÐÀÚ °øµ¿¿¬±¸»ç¾÷ º´¡¦

    2023-06-22
  • °í´ë±¸·Îº´¿ø, 2022³â ¿¬±¸Á߽ɺ´¿ø ½ÉÆ÷Áö¾ö °³ÃÖ_ÀÇ¡¦

    2023-06-22
  • °í·Á´ëÇб³ Àǰú´ëÇÐ ±èº´Á¶¡¤¼­ÀçÈ« ±³¼ö, '2022 º¸¡¦

    2023-06-22
  • ¡®ÀÇ·á¿ë VR ÄÜÅÙÃ÷ °³¹ß¡¯ À§ÇÑ MOU ü°á_ Ŭ·¡½ººê¡¦

    2022-01-13
  • ¾Ï »ýÁ¸ÀÚ °ü¸®

    2023-08-10
  • ½Å¾à°³¹ß¿¡¼­ÀÇ KMEDIhub ¿ªÇÒ ¹× ÀǾàÈ­ÇÐ ±â¼ú¼Ò°³

    2023-04-07
  • FDA approved development process of paclitaxel drug delivery system

    2022-12-20
  • dentification and isolation of active ingredients from natural products

    2022-11-15
  • ÇÕ¼º½Å¾à °³¹ß Ãʱ⿬±¸ ¹× Èĺ¸¹°Áú µµÃâ±îÁö ÇʼöÀûÀÎ °í·Á»çÇ×

    2022-09-13
  • New Drug Development Process&Strategy

    2022-08-31
¿¬±¸¾÷Àû ÃÊû¼¼¹Ì³ª
  • TUMOR-INFILTRATING LYMPHOCYTE THERAPY IN ADVANCED...

    ½Å»ó¿ø
    2023-03
  • RANDOMIZED TRIAL OF TEPOTINIB PLUS GEFITINIB VERSUS...

    ½Å»ó¿ø
    2023-05
  • OVER-EXPRESSION OF LONG NON-CODING RNA UROTHELIAL ...

    ±èöȯ
    2023-07
  • PREDICTION OF AXILLARY LYMPH NODE METASTASIS IN EARLY-STAGE...

    ¹Ú°æÈ­
    2023-09
  • GENOMIC SIGNATURES FROM CLINICAL TUMOR SEQUENCING IN...

    ¹Ú°æÈ­
    2023-01
  • PIK3CA MUTATION IS ASSOCIATED WITH POOR RESPONSE TO...

    ¹Ú°æÈ­
    2023-04
  • 2023³â 8¿ù ¾Ï ¿¬±¸¼Ò ¼¼¹Ì³ª

  • 2023³â 4¿ù ¾Ï ¿¬±¸¼Ò ¼¼¹Ì³ª

  • 2022³â 12¿ù ¾Ï ¿¬±¸¼Ò ¼¼¹Ì³ª

  • 2022³â 11¿ù ¾Ï ¿¬±¸¼Ò ¼¼¹Ì³ª

ADD : ¿ì) 08308 ¼­¿ï½Ã ±¸·Î±¸ ±¸·Îµ¿·Î 148 °í·Á´ëÇб³ ºÎ¼Óº´¿ø ¾Ï ¿¬±¸¼Ò
Copyright by GnGlobal All Rights Reserved.